At Sonoma Bio we believe in balance.

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system.

Sonomabio Lab 0027 1 Aspect Ratio 262 353
Dscf4404 Aspect Ratio 251 353

Founded by pioneers in Treg biology and cell therapy, we are employing proprietary platform technologies and approaches to develop a new generation of targeted and durable Treg cell therapies designed to cure autoimmune and inflammatory diseases.

Founding Story

Our company is founded and led by pioneers in Treg biology and cell therapy.

Sonomabio Conferenceroom 0043 1 Aspect Ratio 940 646

Vision, Mission, and Values

The way we do things is as important as the things we do.

Dscf4337 Aspect Ratio 463 446

Our People & Culture

We are an equally passionate and collaborative team executing on Sonoma’s vision.

Dscf4164 Aspect Ratio 1708 1341

The Founders

Meet the four founders of Sonoma Bio.



Our company’s leaders are leaders in the industry.

Dscf4193 Aspect Ratio 5559 5236

Scientific Advisory Board

Our Scientific Advisory Board includes co-founders of Sonoma Bio. 

Dscf4459 Aspect Ratio 1213 915

Board of Directors

Sonoma Bio’s board of accomplished professionals provides diverse perspectives.

Klausnerrick Headshot 032422 Scaled Aspect Ratio 1707 2374